FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass III · Drug · Recalled May 6, 2026

Lidocaine Wound Gel (Benzalkonium Chloride recall — Water-Jel Technologies, LLC

Hazard: Failed PH Specifications

Class III: not likely to cause adverse health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0509-2026
Brand
Water-Jel Technologies
Classification
Class III
Units affected
31,488 tubes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950

Affected products

Companies & origin

Recalling firm location
Huntersville, NC, United States
Firm address
13359 Reese Blvd East, 28078

Identifying details (verbatim from the notice)

Product codes / lots
Lots: A5014, A5018, A5019
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
98737
Recall initiated
April 7, 2026
FDA classified
April 30, 2026
FDA report date
May 6, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page